Payment overview · 2025
General Payments
$117.48
1 reported records · 1 companies
Healthcare provider profile · identity verified
Richard Fleming, MD
Allopathic & Osteopathic Physicians|Family Medicine · MCALLEN, TX · NPI 1548232531
Verified facts
What the public records show
CMS Open Payments records show Richard Fleming, MD received $117.48 in general payments during 2025 across 1 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $117.48 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $117.48 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| UZEDY Normalized: uzedy |
Drug | Teva Pharmaceuticals USA, Inc. | $117.48 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 618 | 104 |
| Memantine Hcl | Memantine Hcl | 554 | 64 |
| Levothyroxine Sodium | Levothyroxine Sodium | 532 | 71 |
| Donepezil Hcl | Donepezil Hcl | 380 | 54 |
| Lactulose | Lactulose | 380 | 87 |
| Potassium Chloride | Potassium Chloride | 335 | 60 |
| Levetiracetam | Levetiracetam | 334 | 49 |
| Trazodone Hcl | Trazodone Hcl | 314 | 40 |
| Gabapentin | Gabapentin | 288 | 42 |
| Eliquis | Apixaban | 280 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 274 | 51 |
| Amlodipine Besylate | Amlodipine Besylate | 264 | 48 |
| Losartan Potassium | Losartan Potassium | 264 | 49 |
| Famotidine | Famotidine | 227 | 44 |
| Furosemide | Furosemide | 210 | 47 |
| Metformin Hcl | Metformin Hcl | 205 | 30 |
| Lisinopril | Lisinopril | 192 | 31 |
| Clopidogrel | Clopidogrel Bisulfate | 183 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 181 | 20 |
| Metoprolol Succinate | Metoprolol Succinate | 179 | 29 |
| Tamsulosin Hcl | Tamsulosin Hcl | 176 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 173 | 50 |
| Sertraline Hcl | Sertraline Hcl | 171 | 23 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 164 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 163 | 41 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 141 | 16 |
| Mirtazapine | Mirtazapine | 138 | 29 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 130 | 12 |
| Montelukast Sodium | Montelukast Sodium | 122 | 18 |
| Finasteride | Finasteride | 117 | 14 |
| Ondansetron Hcl | Ondansetron Hcl | 113 | 58 |
| Myrbetriq | Mirabegron | 104 | suppressed |
| Enulose | Lactulose | 103 | 19 |
| Olanzapine | Olanzapine | 96 | 17 |
| Nifedipine Er | Nifedipine | 90 | 19 |
| Baclofen | Baclofen | 82 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 81 | suppressed |
| Omeprazole | Omeprazole | 70 | 17 |
| Carvedilol | Carvedilol | 69 | 18 |
| Spironolactone | Spironolactone | 69 | 18 |
| Alendronate Sodium | Alendronate Sodium | 68 | 12 |
| Glipizide | Glipizide | 68 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 61 | 14 |
| Oxcarbazepine | Oxcarbazepine | 60 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 59 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 59 | 13 |
| Sodium Chloride | 0.9 % Sodium Chloride | 59 | 40 |
| Xarelto | Rivaroxaban | 58 | suppressed |
| Risperidone | Risperidone | 57 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 56 | suppressed |
| Latanoprost | Latanoprost | 55 | 12 |
| Ropinirole Hcl | Ropinirole Hcl | 51 | suppressed |
| Bumetanide | Bumetanide | 50 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 49 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 47 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 47 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 45 | 30 |
| Entresto | Sacubitril/Valsartan | 45 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 45 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 45 | 16 |
| Clonazepam | Clonazepam | 44 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 43 | 25 |
| Levofloxacin | Levofloxacin | 43 | 31 |
| Simvastatin | Simvastatin | 43 | 11 |
| Tramadol Hcl | Tramadol Hcl | 42 | 12 |
| Midodrine Hcl | Midodrine Hcl | 41 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 41 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 41 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 40 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 39 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 39 | 21 |
| Azithromycin | Azithromycin | 38 | 29 |
| Doxepin Hcl | Doxepin Hcl | 37 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 24 |
| Enalapril Maleate | Enalapril Maleate | 37 | suppressed |
| Gemtesa | Vibegron | 37 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 37 | suppressed |
| Valsartan | Valsartan | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 36 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 35 | suppressed |
| Humulin R | Insulin Regular, Human | 35 | 16 |
| Lokelma | Sodium Zirconium Cyclosilicate | 34 | suppressed |
| Ranolazine Er | Ranolazine | 34 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 34 | suppressed |
| Amantadine | Amantadine Hcl | 33 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 31 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 31 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 30 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 30 | suppressed |
| Tradjenta | Linagliptin | 30 | suppressed |
| Cefdinir | Cefdinir | 29 | 17 |
| Hydrocortisone | Hydrocortisone | 29 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 27 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 27 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 26 | suppressed |
| Meropenem | Meropenem | 26 | 16 |
| Alprazolam | Alprazolam | 25 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 25 | suppressed |
| Dutasteride | Dutasteride | 25 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 25 | suppressed |
| Lovastatin | Lovastatin | 25 | suppressed |
| Novolin R Flexpen | Insulin Regular, Human | 25 | 14 |
| Prednisone | Prednisone | 25 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 15 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 23 | 17 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Glucagon Emergency Kit | Glucagon | 22 | 17 |
| Neomycin Sulfate | Neomycin Sulfate | 21 | suppressed |
| Phenytoin | Phenytoin | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 21 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 21 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 20 | suppressed |
| Ceftriaxone | Ceftriaxone In Is-Osm Dextrose | 20 | 16 |
| Glimepiride | Glimepiride | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | 12 |
| Icosapent Ethyl | Icosapent Ethyl | 20 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 20 | suppressed |
| Atenolol | Atenolol | 19 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 19 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 19 | 13 |
| Megestrol Acetate | Megestrol Acetate | 19 | 13 |
| Restasis | Cyclosporine | 19 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 19 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 19 | 15 |
| Vraylar | Cariprazine Hcl | 19 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 18 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 18 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 18 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 18 | suppressed |
| Lorazepam | Lorazepam | 18 | suppressed |
| Timolol Maleate | Timolol Maleate | 18 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 17 | suppressed |
| Fentanyl | Fentanyl | 17 | suppressed |
| Rivastigmine | Rivastigmine | 17 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 16 | suppressed |
| Calcitriol | Calcitriol | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 16 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Pregabalin | Pregabalin | 16 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 15 | suppressed |
| Ertapenem | Ertapenem Sodium | 15 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 15 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Novolin R | Insulin Regular, Human | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Xifaxan | Rifaximin | 15 | suppressed |
| Allopurinol | Allopurinol | 14 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | 11 |
| Clotrimazole | Clotrimazole | 14 | 11 |
| Digoxin | Digoxin | 14 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 14 | suppressed |
| Letrozole | Letrozole | 14 | suppressed |
| Linzess | Linaclotide | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 14 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Jardiance | Empagliflozin | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Nystatin | Nystatin | 12 | suppressed |
| Temazepam | Temazepam | 12 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 11 | suppressed |
| Brinzolamide | Brinzolamide | 11 | suppressed |
| Cilostazol | Cilostazol | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 11 | suppressed |
| Mirabegron Er | Mirabegron | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 11 | suppressed |
| Sulfasalazine | Sulfasalazine | 11 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 11 | suppressed |
| Trifluoperazine Hcl | Trifluoperazine Hcl | 11 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $117.48 · 1 records | Teva Pharmaceuticals USA, Inc. | UZEDY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error